Prenatal kynurenine exposure in rats: age-dependent changes in NMDA receptor expression and conditioned fear responding

Psychopharmacology

Volumn 233, Issue 21-22, 2016, Pages 3725-3735

  Pershing, Michelle L ^a   Phenis, David ^a   Valentini, Valentina ^b   Pocivavsek, Ana ^c   Lindquist, Derick H ^a   Schwarcz, Robert ^c   Bruno, John P ^a  

^a OHIO STATE UNIVERSITY   (United States)

^b UNIVERSITY OF CAGLIARI   (Italy)

^c UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

alpha7 nicotinic receptors; Glutamate; Kynurenic acid; N Methyl d aspartate receptors; Prefrontal cortex; Schizophrenia; Trace fear conditioning

Indexed keywords

BUNGAROTOXIN RECEPTOR; KYNURENIC ACID; KYNURENINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 1; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 2A; CHRNA7 PROTEIN, RAT; N-METHYL D-ASPARTATE RECEPTOR SUBTYPE 2A; NR1 NMDA RECEPTOR; NR2B NMDA RECEPTOR;

ADULT; ADULTHOOD; AGE DISTRIBUTION; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN LEVEL; COGNITION; COGNITIVE DEFECT; CONDITIONING; CONTROLLED STUDY; EMBRYO DEVELOPMENT; GENE EXPRESSION; JUVENILE; MALE; NONHUMAN; PRENATAL EXPOSURE; PRIORITY JOURNAL; RAT; SCHIZOPHRENIA; TASK PERFORMANCE; TRACE FEAR CONDITIONING; YOUNG ADULT; AGE; ANIMAL; BRAIN; DRUG EFFECTS; FEAR; FEMALE; HUMAN; METABOLISM; PREGNANCY;

AGE FACTORS; ALPHA7 NICOTINIC ACETYLCHOLINE RECEPTOR; ANIMALS; BRAIN; COGNITION; CONDITIONING (PSYCHOLOGY); FEAR; FEMALE; HUMANS; KYNURENIC ACID; KYNURENINE; MALE; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; RATS; RECEPTORS, N-METHYL-D-ASPARTATE; SCHIZOPHRENIA;

EID: 84982175060     PISSN: 00333158     EISSN: 14322072     Source Type: Journal    
DOI: 10.1007/s00213-016-4404-9     Document Type: Article

References (80)

1. Abdel-Tawab GA, El-Zoghby SM, Saad AA (1975) Relationship between pyridoxal phosphate and some synthetic oestrogens, gonadotropin and thyroxine in their effects on kynurenine hydrolase and kynurenine aminotransferase enzymes of normal mouse liver. Acta Vitaminol Enzymol 29:326–331
2. Akagbosu CO, Evans GC, Gulick D, Suckow RF, Bucci DJ (2012) Exposure to kynurenic acid during adolescence produces memory deficits in adulthood. Schizophr Bull 38:769–778
3. Akbarian S, Bunney WE Jr, Potkin SG, Wigal SB, Hagman JO, Sandman CA, Jones EG (1993) Altered distribution of nicotinamide-adenine dinucleotide phosphate-diaphorase cells in frontal lobe of schizophrenics implies disturbances of cortical development. Arch Gen Psychiat 50:169–177
4. Albuquerque EX, Schwarcz R (2013) Kynurenic acid as an antagonist of alpha7 nicotinic acetylcholine receptors in the brain: facts and challenges. Biochem Pharmacol 85:1027–1032
5. Aoyama N, Takahashi N, Saito S, Maeno N, Ishihara R, Ji X, Miura H, Ikeda M, Suzuki T, Kitajima T, et al. (2006) Association study between kynurenine 3-monooxygenase gene and schizophrenia in the Japanese population. Genes Brain Behav 5:364–368
6. Barnet RC, Hunt PS (2005) Trace and long-delay fear conditioning in the developing rat. Learn and Behav 33:437–443
7. Beggiato S, Tanganelli S, Fuxe K, Antonelli T, Schwarcz R, Ferraro L (2014) Endogenous kynurenic acid regulates extracellular GABA levels in the rat prefrontal cortex. Neuropharmacology 82:11–18
8. Benes FM, Vincent SL, Todtenkopf M (2001) The density of pyramidal and nonpyramidal neurons in anterior cingulate cortex of schizophrenic and bipolar subjects. Biol Psychiat 50:395–406
9. Brebion G, David AS, Jones HM, Ohlsen R, Pilowsky LS (2007) Temporal context discrimination in patients with schizophrenia: associations with auditory hallucinations and negative symptoms. Neuropsychologia 45:817–823
10. Chess AC, Landers AM, Bucci DJ (2009) L-kynurenine treatment alters contextual fear conditioning and context discrimination but not cue-specific fear conditioning. Behav Brain Res 201:325–331
11. Cui, Y., Jin, J., Zhang, X., Xu, H., Yang, L., Du, D., Zeng, Q., Tsien, J.Z., Yu, H., and Cao, X. (2011). Forebrain NR2B overexpression facilitating the prefrontal cortex long-term potentiation and enhancing working memory function in mice. PLoS One e20312
12. Danesch U, Gloss B, Schmid W, Schutz G, Schule R, Renkawitz R (1987) Glucocorticoid induction of the rat tryptophan oxygenase gene is mediated by two widely separated glucocorticoid-responsive elements. EMBO J 6:625–630
13. Danesch U, Hashimoto S, Renkawitz R, Schutz G (1983) Transcriptional regulation of the tryptophan oxygenase gene in rat liver by glucocorticoids. J Biol Chem 258:4750–4753
14. Davis J, Eyre H, Jacka FN, Dodd S, Dean O, McEwen S, Debnath M, McGrath J, Maes M, Amminger P, et al. (2016) A review of vulnerability and risks for schizophrenia: beyond the two hit hypothesis. Neurosci Biobehav Rev 65:185–194
15. DeAngeli NE, Todd TP, Chang SE, Yeh HH, Yeh PW, Bucci DJ (2014) Exposure to kynurenic acid during adolescence increases sign-tracking and impairs long-term potentiation in adulthood. Front Behav Neurosci 8:451
16. Erhardt S, Blennow K, Nordin C, Skogh E, Lindstrom LH, Engberg G (2001) Kynurenic acid levels are elevated in the cerebrospinal fluid of patients with schizophrenia. Neurosci Lett 313:96–98
17. Erhardt S, Olsson SK, Engberg G (2009) Pharmacological manipulation of kynurenic acid: potential in the treatment of psychiatric disorders. CNS Drugs 23:91–101
18. Erreger K, Dravid SM, Banke TG, Wyllie DJ, Traynelis SF (2005) Subunit-specific gating controls rat NR1/NR2A and NR1/NR2B NMDA channel kinetics and synaptic signalling profiles. J Phys 563:345–358
19. Fanselow MS (1980) Conditional and unconditional components of post-shock freezing. Pavlovian J Biol Sci:177–182
20. Feinberg I (1982) Schizophrenia: caused by a fault in programmed synaptic elimination during adolescence? J Psychiat Res 17:319–334
21. Flores-Barrera E, Thomases DR, Heng LJ, Cass DK, Caballero A, Tseng KY (2014) Late adolescent expression of GluN2B transmission in the prefrontal cortex is input-specific and requires postsynaptic protein kinase A and D1 dopamine receptor signaling. Biol Psychiat 75:508–516
22. Forrest CM, Khalil OS, Pisar M, Darlington LG, Stone TW (2013) Prenatal inhibition of the tryptophan-kynurenine pathway alters synaptic plasticity and protein expression in the rat hippocampus. Brain Res 1504:1–15
23. Forrest CM, McNair K, Pisar M, Khalil OS, Darlington LG, Stone TW (2015) Altered hippocampal plasticity by prenatal kynurenine administration, kynurenine-3-monoxygenase (KMO) deletion or galantamine. Neuroscience 310:91–105
24. Gal EM, Sherman AD (1978) Synthesis and metabolism of L-kynurenine in rat brain. J Neurochem 30:607–613
25. Gibney SM, Fagan EM, Waldron AM, O’Byrne J, Connor TJ, Harkin A (2014) Inhibition of stress-induced hepatic tryptophan 2,3-dioxygenase exhibits antidepressant activity in an animal model of depressive behaviour. Int J Neuropsychopharmacol 17:917–928
26. Gilmartin MR, Balderston NL, Helmstetter FJ (2014) Prefrontal cortical regulation of fear learning. Trends Neurosci 37:455–464
27. Gilmartin MR, Kwapis JL, Helmstetter FJ (2013) NR2A- and NR2B-containing NMDA receptors in the prelimbic medial prefrontal cortex differentially mediate trace, delay, and contextual fear conditioning. Learn Memory 20:290–294
28. Gilmartin MR, McEchron MD (2005) Single neurons in the medial prefrontal cortex of the rat exhibit tonic and phasic coding during trace fear conditioning. Behav Neurosci 119:1496–1510
29. Giza CC, Maria NS, Hovda DA (2006) N-Methyl-D-aspartate receptor subunit changes after traumatic injury to the developing brain. J Neurotraum 23:950–961
30. Glausier JR, Lewis DA (2013) Dendritic spine pathology in schizophrenia. Neuroscience 251:90–107
31. Goodfellow MJ, Abdulla KA, Lindquist DH (2016) Neonatal ethanol exposure impairs trace fear conditioning and alters NMDA receptor subunit expression in adult male and female rats. Alcohol Clin Exp Res 40:309–318
32. Gramsbergen JB, Hodgkins PS, Rassoulpour A, Turski WA, Guidetti P, Schwarcz R (1997) Brain-specific modulation of kynurenic acid synthesis in the rat. J Neurochem 69:290–298
33. Green MF (1996) What are the functional consequences of neurocognitive deficits in schizophrenia? Am J Psychiat 153:321–330
34. Green MF, Kern RS, Heaton RK (2004) Longitudinal studies of cognition and functional outcome in schizophrenia: implications for MATRICS. Schizophr Res 72:41–51
35. Hashimoto K (2014) Targeting of NMDA receptors in new treatments for schizophrenia. Expert Opin Ther Targets 18:1049–1063
36. Hemsley DR (2005) The schizophrenic experience: taken out of context? Schizophr Bull 31:43–53
37. Jansson LC, Akerman KE (2014) The role of glutamate and its receptors in the proliferation, migration, differentiation and survival of neural progenitor cells. J Neural Transm 121:819–836
38. Kegel ME, Bhat M, Skogh E, Samuelsson M, Lundberg K, Dahl ML, Sellgren C, Schwieler L, Engberg G, Schuppe-Koistinen I, et al. (2014) Imbalanced kynurenine pathway in schizophrenia. Int J Tryptophan Res 7:15–22
39. Kessler M, Terramani T, Lynch G, Baudry M (1989) A glycine site associated with N-methyl-D-aspartic acid receptors: characterization and identification of a new class of antagonists. J Neurochem 52:1319–1328
40. King EC, Pattwell SS, Glatt CE, Lee FS (2014) Sensitive periods in fear learning and memory. Stress 17:13–21
41. Konradsson-Geuken A, Gash CR, Alexander K, Pomerleau F, Huettl P, Gerhardt GA, Bruno JP (2009) Second-by-second analysis of alpha 7 nicotine receptor regulation of glutamate release in the prefrontal cortex of awake rats. Synapse 63:1069–1082
42. Konradsson-Geuken A, Wu HQ, Gash CR, Alexander KS, Campbell A, Sozeri Y, Pellicciari R, Schwarcz R, Bruno JP (2010) Cortical kynurenic acid bi-directionally modulates prefrontal glutamate levels as assessed by microdialysis and rapid electrochemistry. Neuroscience 169:1848–1859
43. Lewis DA (1997) Development of the prefrontal cortex during adolescence: insights into vulnerable neural circuits in schizophrenia. Neuropsychopharmacol 16:385–398
44. Lin H, Hsu FC, Baumann BH, Coulter DA, Anderson SA, Lynch DR (2014a) Cortical parvalbumin GABAergic deficits with alpha7 nicotinic acetylcholine receptor deletion: implications for schizophrenia. Mol Cell Neurosci 61:163–175
45. Lin H, Hsu FC, Baumann BH, Coulter DA, Lynch DR (2014b) Cortical synaptic NMDA receptor deficits in alpha7 nicotinic acetylcholine receptor gene deletion models: implications for neuropsychiatric diseases. Neurobiol Dis 63:129–140
46. Linderholm KR, Skogh E, Olsson SK, Dahl ML, Holtze M, Engberg G, Samuelsson M, Erhardt S (2012) Increased levels of kynurenine and kynurenic acid in the CSF of patients with schizophrenia. Schizophr Bull 38:426–432
47. McGinty F, Rose DP (1969) Influence of androgens upon tryptophan metabolism in man. Life Sci 8:1193–1199
48. Millan MJ, Agid Y, Brune M, Bullmore ET, Carter CS, Clayton NS, Connor R, Davis S, Deakin B, DeRubeis RJ, et al. (2012) Cognitive dysfunction in psychiatric disorders: characteristics, causes and the quest for improved therapy. Nat Rev Drug Discov 11:141–168
49. Miller CL, Llenos IC, Dulay JR, Barillo MM, Yolken RH, Weis S (2004) Expression of the kynurenine pathway enzyme tryptophan 2,3-dioxygenase is increased in the frontal cortex of individuals with schizophrenia. Neurobiol Dis 15:618–629
50. Nielsen DM, Crnic LS (2002) Automated analysis of foot-shock sensitivity and concurrent freezing behavior in mice. J Neurosci Meth 115:199–209
51. Notarangelo FM, Pocivavsek A (2016) Elevated kynurenine pathway metabolism during neurodevelopment: implications for brain and behavior. Neuropharmacology doi 10:1016
52. O’Donnell P (2011) Adolescent onset of cortical disinhibition in schizophrenia: insights from animal models. Schizophr Bull 37:484–492
53. Ohgi Y, Futamura T, Hashimoto K (2015) Glutamate signaling in synaptogenesis and NMDA receptors as potential therapeutic targets for psychiatric disorders. Curr Mol Med 15:206–221
54. Pattwell SS, Duhoux S, Hartley CA, Johnson DC, Jing D, Elliott MD, Ruberry EJ, Powers A, Mehta N, Yang RR, et al. (2012) Altered fear learning across development in both mouse and human. PNAS USA 109:16318–16323
55. Perkins MN, Stone TW (1982) An iontophoretic investigation of the actions of convulsant kynurenines and their interaction with the endogenous excitant quinolinic acid. Brain Res 247:184–187
56. Pershing ML, Bortz DM, Pocivavsek A, Fredericks PJ, Jorgensen CV, Vunck SA, Leuner B, Schwarcz R, Bruno JP (2015) Elevated levels of kynurenic acid during gestation produce neurochemical, morphological, and cognitive deficits in adulthood: implications for schizophrenia. Neuropharmacology 90:33–41
57. Pocivavsek A, Notarangelo FM, Wu HQ, Bruno JP, Schwarcz R (2016) Astrocytes as pharmacological targets in the treatment of schizophrenia: focus on kynurenic acid. In: Pletnikov M, Waddington J (eds) Modeling the psychopathological dimensions of schizophrenia. Academic Press, New York, pp. 423–443
58. Pocivavsek A, Thomas MA, Elmer GI, Bruno JP, Schwarcz R (2014) Continuous kynurenine administration during the prenatal period, but not during adolescence, causes learning and memory deficits in adult rats. Psychopharm 231:2799–2809
59. Rao PK, Kumar RM, Farkhondeh M, Baskerville S, Lodish HF (2006) Myogenic factors that regulate expression of muscle-specific microRNAs. PNAS USA 103:8721–8726
60. Raybuck JD, Gould TJ (2010) The role of nicotinic acetylcholine receptors in the medial prefrontal cortex and hippocampus in trace fear conditioning. Neurobiol Learn Mem 94:353–363
61. Rimol LM, Hartberg CB, Nesvag R, Fennema-Notestine C, Hagler DJ Jr, Pung CJ, Jennings RG, Haukvik UK, Lange E, Nakstad PH, et al. (2010) Cortical thickness and subcortical volumes in schizophrenia and bipolar disorder. Biol Psychiat 68:41–50
62. Sathyasaikumar KV, Stachowski EK, Wonodi I, Roberts RC, Rassoulpour A, McMahon RP, Schwarcz R (2011) Impaired kynurenine pathway metabolism in the prefrontal cortex of individuals with schizophrenia. Schizophr Bull 37:1147–1156
63. Schmittgen TD, Livak KJ (2008) Analyzing real-time PCR data by the comparative C(T) method. Nat Protoc 3:1101–1108
64. Schwarcz R, Bruno JP, Muchowski PJ, Wu HQ (2012) Kynurenines in the mammalian brain: when physiology meets pathology. Nat Rev: Neurosci 13:465–477
65. Schwarcz R, Rassoulpour A, Wu HQ, Medoff D, Tamminga CA, Roberts RC (2001) Increased cortical kynurenate content in schizophrenia. Biol Psychiat 50:521–530
66. Selemon LD, Zecevic N (2015) Schizophrenia: a tale of two critical periods for prefrontal cortical development. Transl Psychiatry 5:e623
67. Shouval HZ, Bear MF, Cooper LN (2002) A unified model of NMDA receptor-dependent bidirectional synaptic plasticity. PNAS USA 99:10831–10836
68. Stone TW, Darlington LG (2013) The kynurenine pathway as a therapeutic target in cognitive and neurodegenerative disorders. Brit J Pharmacol 169:1211–1227
69. Tang YP, Shimizu E, Dube GR, Rampon C, Kerchner GA, Zhuo M, Liu G, Tsien JZ (1999) Genetic enhancement of learning and memory in mice. Nature 401:63–69
70. Thomsen MS, Mikkelsen JD (2012) The alpha7 nicotinic acetylcholine receptor complex: one, two or multiple drug targets? Curr Drug Targets 13:707–720
71. Vasey MW, Thayer JF (1987) The continuing problem of false positives in repeated measures ANOVA in psychophysiology: a multivariate solution. Psychophysiology 24:479–486
72. Wang H, Stradtman GG, Wang XJ, Gao WJ (2008) A specialized NMDA receptor function in layer 5 recurrent microcircuitry of the adult rat prefrontal cortex. PNAS USA 105:16791–16796
73. Wang M, Yang Y, Wang CJ, Gamo NJ, Jin LE, Mazer JA, Morrison JH, Wang XJ, Arnsten AF (2013) NMDA receptors subserve persistent neuronal firing during working memory in dorsolateral prefrontal cortex. Neuron 77:736–749
74. Waters FA, Maybery MT, Badcock JC, Michie PT (2004) Context memory and binding in schizophrenia. Schizophr Res 68:119–125
75. Wonodi I, Stine OC, Sathyasaikumar KV, Roberts RC, Mitchell BD, Hong LE, Kajii Y, Thaker GK, Schwarcz R (2011) Downregulated kynurenine 3-monooxygenase gene expression and enzyme activity in schizophrenia and genetic association with schizophrenia endophenotypes. Arch Gen Psychiat 68:665–674
76. Wright IC, Rabe-Hesketh S, Woodruff PW, David AS, Murray RM, Bullmore ET (2000) Meta-analysis of regional brain volumes in schizophrenia. Am J Psychiat 157:16–25
77. Wu HQ, Okuyama M, Kajii Y, Pocivavsek A, Bruno JP, Schwarcz R (2014) Targeting kynurenine aminotransferase II in psychiatric diseases: promising effects of an orally active enzyme inhibitor. Schizophr Bull 40(Suppl 2):S152–S158
78. Wu HQ, Pereira EF, Bruno JP, Pellicciari R, Albuquerque EX, Schwarcz R (2010) The astrocyte-derived alpha7 nicotinic receptor antagonist kynurenic acid controls extracellular glutamate levels in the prefrontal cortex. J Mol Neurosci 40:204–210
79. Xu Z, Chen RQ, Gu QH, Yan JZ, Wang SH, Liu SY, Lu W (2009) Metaplastic regulation of long-term potentiation/long-term depression threshold by activity dependent changes of NR2A/NR2B ratio. J Neurosci 29:10
80. Yashiro K, Philpot B (2008) Regulation of NMDA receptor subunit expression and its implications for LTD, LTP, and metaplasticity. Neuropharmacology 55:14